For the Inventor, By the Inventor

Enter assignee name

Prague, Czechia

Institute of Organic Chemistry and Biochemistry Ascr, V.v.i.

USPTO Granted Patents = 14

CIPO Patents = 3

EPO Patents = 16

Forward Citations = 17

Loading Chart...

Loading Chart...

35 inventors (with patents filed for the assignee):

Gabriel Birkus (6 out of 6 patents)

Ondrej Pav (6 out of 6 patents)

Rana Rais (5 out of 18 patents)

4. Barbara S Slusher (5 out of 80 patents)

5. Tomas Tichy (4 out of 7 patents)

6. Pavel Majer (4 out of 27 patents)

7. Andrej Jancarik (4 out of 12 patents)

8. Ivan Rosenberg (4 out of 4 patents)

9. Marcela Krecmerova (3 out of 6 patents)

10. Ondrej Simak (3 out of 3 patents)

11. Radim Nencka (3 out of 3 patents)

12. Lukas Tenora (3 out of 12 patents)

13. Michal Hocek (2 out of 8 patents)

14. Tomas Jandusik (2 out of 2 patents)

15. Jan Vavra (2 out of 3 patents)

14 patents: Sort by Forward Citations

1. 12492160 - Prodrugs of itaconate and methyl itaconate (2025-12-09),

2. 12318403 - 2'3′-cyclic dinucleotides and prodrugs thereof (2025-06-03),

3. 11932664 - Prodrugs of prostate specific membrane antigen (PSMA) inhibitor (2024-03-19),

4. 11866394 - Prodrugs of hydroxamate-based GCPII inhibitors (2024-01-09),

5. 11766447 - 3'3′-cyclic dinucleotide analogue comprising a cyclopentanyl modified nucleotide as sting modulator (2023-09-26),

6. 11712435 - Mebendazole prodrugs with enhanced solubility and oral bioavailability (2023-08-01),

7. 11292812 - 3'3′-cyclic dinucleotides (2022-04-05),

8. 11203610 - 2'3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein (2021-12-21),

9. 11149052 - 2'3′-cyclic dinucleotides (2021-10-19),

10. 10966999 - 3'3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein (2021-04-06),

11. 10294262 - 7-deazapurine nucleosides for therapeutic uses (2019-05-21),

12. 9988407 - Prodrugs of prostate specific membrane antigen (PSMA) inhibitor (2018-06-05),

13. 9586986 - Substituted 7-deazapurine ribonucleosides for therapeutic uses (2017-03-07),

14. 9200020 - 6-oxopurine phosphoribosyltransferase inhibitors (2015-12-01),

The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB) is a leading scientific institution in the Czech Republic, focusing on research in organic chemistry and biochemistry. It conducts cutting-edge research in various fields, such as drug discovery, chemical biology, and materials science. With a team of talented researchers and state-of-the-art facilities, IOCB is at the forefront of innovation and scientific discovery.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

14 Patents

#12 in Prague

#29 in Czechia

#40,929 in the World

Prague, Czechia

Institute of Organic Chemistry and Biochemistry Ascr, V.v.i.

Forward Citations = 17

35 inventors:

Gabriel Birkus (6 out of 6 patents)

Ondrej Pav (6 out of 6 patents)

Rana Rais (5 out of 18 patents)

4. Barbara S Slusher (5 out of 80 patents)

5. Tomas Tichy (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…